Understanding Exosome Therapy
By Jed Ryan, Founder and CEO · Reviewed by Adas Darinskas, PhD, Chief Science Officer · Published · Last reviewed
Exosomes are tiny vesicles that cells use to send signals to one another, the body's messengers. When they come from stem cells, they carry proteins, lipids, and RNA that tell other cells to repair, calm inflammation, and get back to normal function.
Because exosomes are small and carry no cells of their own, they can cross the blood-brain barrier, avoid many of the immune-rejection concerns of whole-cell therapies, and be produced and stored at scale.
Exosomes were once written off as cellular waste. Over the past decade research has shown they're actually one of the main ways cells communicate over distance, and that opens up real therapeutic potential.
When derived from MSCs under GMP conditions, exosome preparations carry a biologically active cargo and work through several routes:
- Paracrine signalling: Instruct nearby cells to regenerate, reduce inflammation, or restore normal function
- BBB penetration: Small enough to cross the blood-brain barrier and reach neurological targets
- Acellular delivery: No living cells means lower immunogenicity risk compared to whole-cell therapies
- Scalable manufacturing: Can be produced in large quantities and stored without loss of potency
At Innovita Clinic, exosome preparations are derived from high-quality stem cell cultures using GMP manufacturing protocols.
